You just read:

Sirona Dx Launches Novel Urine-Based Bladder Cancer Assay with PD-L1 Quantification Based on IncellDx's Single Cell Immuno-Oncology/PD-L1 Technology

News provided by

IncellDx, Inc.

Oct 30, 2018, 07:00 ET